← Back to Search

Adaptive Naming Treatment Schedules for Aphasia

Phase 2
Recruiting
Led By William Evans, PhD
Research Sponsored by University of Pittsburgh
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Must not have
Severe diagnosed mood or behavioral disorders that require specialize mental health interventions.
History of other acquired or progressive neurological disease.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up initial assessment (pre-treatment), multiple timepoints up to 6-months post-treatment.
Awards & highlights
No Placebo-Only Group

Summary

This trial evaluates novel treatments to help people with aphasia (language disorder) improve their ability to find words, with a focus on long-term retention and use in everyday life.

Who is the study for?
This trial is for people who have had a stroke leading to aphasia, a language disorder, and struggle with finding words. They must be at least six months post-stroke, show specific difficulties on the Comprehensive Aphasia Test, and can use telehealth services via high-speed internet. It's not for those with other neurological diseases, severe comprehension issues, uncontrolled substance dependence or serious mood disorders.
What is being tested?
The study tests three different ways of scheduling picture-based naming exercises to help improve long-term word recall and usage in daily life for individuals with aphasia. Participants will try adaptive spacing (adjusting intervals based on performance), or one of two fixed schedules with varying amounts of practice items.
What are the potential side effects?
Since this trial involves non-medical interventions like speech therapy exercises conducted through telehealth sessions, there are no direct physical side effects expected from participating in the treatments being tested.

Eligibility Criteria

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have a severe mood or behavioral disorder that needs special mental health care.
Select...
I have a history of a progressive neurological condition.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~initial assessment (pre-treatment), multiple timepoints up to 6-months post-treatment.
This trial's timeline: 3 weeks for screening, Varies for treatment, and initial assessment (pre-treatment), multiple timepoints up to 6-months post-treatment. for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in correct responses in Confrontation Naming of Treated and Untreated Pictured Objects
Change in correct responses in Context Generalization of Treated and Untreated Pictured Objects
Secondary study objectives
Change in core lexicon analysis on the Aphasia Bank Discourse Protocol
Change in mean scores on the Aphasia Communication Outcome Measure Short-Form
Mean score on the Cactus and Camels Test (CCT)
+4 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

6Treatment groups
Experimental Treatment
Group I: Low-item non-adaptive spacing, then high-item non-adaptive spacing, then adaptive spacingExperimental Treatment3 Interventions
All participants will receive all three naming treatment conditions in a randomized order - this is one possible ordering of those conditions.
Group II: Low-item non-adaptive spacing, then adaptive spacing, then high-item non-adaptive spacingExperimental Treatment3 Interventions
All participants will receive all three naming treatment conditions in a randomized order - this is one possible ordering of those conditions.
Group III: High-item non-adaptive spacing, then low-item non-adaptive spacing, then adaptive spacingExperimental Treatment3 Interventions
All participants will receive all three naming treatment conditions in a randomized order - this is one possible ordering of those conditions.
Group IV: High-item non-adaptive spacing, then adaptive spacing, then low-item non-adaptive spacingExperimental Treatment3 Interventions
All participants will receive all three naming treatment conditions in a randomized order - this is one possible ordering of those conditions.
Group V: Adaptive spacing, then low-item non-adaptive spacing, then high-item non-adaptive spacingExperimental Treatment3 Interventions
All participants will receive all three naming treatment conditions in a randomized order - this is one possible ordering of those conditions.
Group VI: Adaptive spacing, then high-item non-adaptive spacing, then low-item non-adaptive spacingExperimental Treatment3 Interventions
All participants will receive all three naming treatment conditions in a randomized order - this is one possible ordering of those conditions.

Find a Location

Who is running the clinical trial?

University of PittsburghLead Sponsor
1,792 Previous Clinical Trials
16,359,954 Total Patients Enrolled
3 Trials studying Aphasia
66 Patients Enrolled for Aphasia
University of Massachusetts, AmherstOTHER
81 Previous Clinical Trials
468,118 Total Patients Enrolled
2 Trials studying Aphasia
54 Patients Enrolled for Aphasia
National Institute on Deafness and Other Communication Disorders (NIDCD)NIH
361 Previous Clinical Trials
182,026 Total Patients Enrolled
39 Trials studying Aphasia
2,792 Patients Enrolled for Aphasia
William Evans, PhDPrincipal InvestigatorUniversity of Pittsburgh
4 Previous Clinical Trials
3,528 Total Patients Enrolled
2 Trials studying Aphasia
50 Patients Enrolled for Aphasia

Media Library

Adaptive Spacing Condition Clinical Trial Eligibility Overview. Trial Name: NCT05653466 — Phase 2
Aphasia Research Study Groups: High-item non-adaptive spacing, then adaptive spacing, then low-item non-adaptive spacing, Adaptive spacing, then high-item non-adaptive spacing, then low-item non-adaptive spacing, Adaptive spacing, then low-item non-adaptive spacing, then high-item non-adaptive spacing, High-item non-adaptive spacing, then low-item non-adaptive spacing, then adaptive spacing, Low-item non-adaptive spacing, then high-item non-adaptive spacing, then adaptive spacing, Low-item non-adaptive spacing, then adaptive spacing, then high-item non-adaptive spacing
Aphasia Clinical Trial 2023: Adaptive Spacing Condition Highlights & Side Effects. Trial Name: NCT05653466 — Phase 2
Adaptive Spacing Condition 2023 Treatment Timeline for Medical Study. Trial Name: NCT05653466 — Phase 2
~21 spots leftby Jan 2027